Cargando…
Effect of famotidine on cognitive and behavioral dysfunctions induced in post-COVID-19 infection: A randomized, double-blind, and placebo-controlled study
OBJECTIVES: This is an investigation of the efficacy and safety of famotidine, a selective histamine H2 receptor antagonist, on improvement of cognitive impairment, depression and anxiety symptoms developing post-COVID-19, in a 12-week, randomized controlled trial. METHODS: A total of 50 patients wi...
Autores principales: | Momtazmanesh, Sara, Ansari, Sahar, Izadi, Zahra, Shobeiri, Parnian, Vatankhah, Venus, Seifi, Arash, Ghiasvand, Fereshteh, Bahrami, Mahboobeh, Salehi, Mohammdreza, Noorbala, Ahmad Ali, Akhondzadeh, Shahin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10229204/ https://www.ncbi.nlm.nih.gov/pubmed/37327698 http://dx.doi.org/10.1016/j.jpsychores.2023.111389 |
Ejemplares similares
-
Orthopedic management of myelomeningocele with a multidisciplinary approach: a systematic review of the literature
por: Shobeiri, Parnian, et al.
Publicado: (2021) -
Cardiovascular disease in COVID-19: a systematic review and meta-analysis of 10,898 patients and proposal of a triage risk stratification tool
por: Momtazmanesh, Sara, et al.
Publicado: (2020) -
Femicomfort in the Treatment of Premenstrual Syndromes: A Double-Blind, Randomized and Placebo Controlled Trial
por: Kashani, Ladan, et al.
Publicado: (2010) -
Famotidine and Coronavirus Disease 2019
por: Freedberg, Daniel E., et al.
Publicado: (2021) -
Famotidine induced hypomagnesemia leading to hypocalcemia
por: Essrani, Rajesh, et al.
Publicado: (2020)